QQQ   311.11 (+1.63%)
AAPL   159.90 (+1.31%)
MSFT   277.14 (+1.78%)
META   204.74 (+2.47%)
GOOGL   105.31 (+1.88%)
AMZN   99.91 (+1.23%)
TSLA   197.68 (+3.42%)
NVDA   273.33 (+3.27%)
NIO   9.37 (+3.08%)
BABA   87.62 (+4.75%)
AMD   101.25 (+3.76%)
T   18.43 (+0.22%)
F   11.69 (+1.83%)
MU   60.54 (+4.07%)
CGC   1.93 (+2.69%)
GE   91.35 (+1.96%)
DIS   95.98 (+1.14%)
AMC   4.58 (+5.53%)
PFE   40.36 (+0.87%)
PYPL   73.21 (-1.52%)
NFLX   320.15 (+8.93%)
QQQ   311.11 (+1.63%)
AAPL   159.90 (+1.31%)
MSFT   277.14 (+1.78%)
META   204.74 (+2.47%)
GOOGL   105.31 (+1.88%)
AMZN   99.91 (+1.23%)
TSLA   197.68 (+3.42%)
NVDA   273.33 (+3.27%)
NIO   9.37 (+3.08%)
BABA   87.62 (+4.75%)
AMD   101.25 (+3.76%)
T   18.43 (+0.22%)
F   11.69 (+1.83%)
MU   60.54 (+4.07%)
CGC   1.93 (+2.69%)
GE   91.35 (+1.96%)
DIS   95.98 (+1.14%)
AMC   4.58 (+5.53%)
PFE   40.36 (+0.87%)
PYPL   73.21 (-1.52%)
NFLX   320.15 (+8.93%)
QQQ   311.11 (+1.63%)
AAPL   159.90 (+1.31%)
MSFT   277.14 (+1.78%)
META   204.74 (+2.47%)
GOOGL   105.31 (+1.88%)
AMZN   99.91 (+1.23%)
TSLA   197.68 (+3.42%)
NVDA   273.33 (+3.27%)
NIO   9.37 (+3.08%)
BABA   87.62 (+4.75%)
AMD   101.25 (+3.76%)
T   18.43 (+0.22%)
F   11.69 (+1.83%)
MU   60.54 (+4.07%)
CGC   1.93 (+2.69%)
GE   91.35 (+1.96%)
DIS   95.98 (+1.14%)
AMC   4.58 (+5.53%)
PFE   40.36 (+0.87%)
PYPL   73.21 (-1.52%)
NFLX   320.15 (+8.93%)
QQQ   311.11 (+1.63%)
AAPL   159.90 (+1.31%)
MSFT   277.14 (+1.78%)
META   204.74 (+2.47%)
GOOGL   105.31 (+1.88%)
AMZN   99.91 (+1.23%)
TSLA   197.68 (+3.42%)
NVDA   273.33 (+3.27%)
NIO   9.37 (+3.08%)
BABA   87.62 (+4.75%)
AMD   101.25 (+3.76%)
T   18.43 (+0.22%)
F   11.69 (+1.83%)
MU   60.54 (+4.07%)
CGC   1.93 (+2.69%)
GE   91.35 (+1.96%)
DIS   95.98 (+1.14%)
AMC   4.58 (+5.53%)
PFE   40.36 (+0.87%)
PYPL   73.21 (-1.52%)
NFLX   320.15 (+8.93%)
NASDAQ:CDMO

Avid Bioservices - CDMO Earnings Date, Estimates & Call Transcripts

$17.53
+0.15 (+0.86%)
(As of 03/23/2023 10:03 AM ET)
Add
Compare
Today's Range
$17.30
$17.61
50-Day Range
$13.82
$18.79
52-Week Range
$11.30
$22.38
Volume
25,748 shs
Average Volume
598,944 shs
Market Capitalization
$1.10 billion
P/E Ratio
10.56
Dividend Yield
N/A
Price Target
$22.33
Skip Charts & View Estimated and Actual Earnings Data

CDMO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CDMO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avid Bioservices Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231$0.03$0.03$0.03 
Q2 20231($0.01)($0.01)($0.01) 
Q3 20231($0.04)($0.04)($0.04) 
Q4 20231($0.02)($0.02)($0.02) 
FY 20234($0.04)($0.04) ($0.04)

CDMO Earnings Date and Information

Avid Bioservices has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 5th, 2023 based off prior year's report dates.

Avid Bioservices Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/5/2023
(Estimated)
        
12/6/2022Q2 2023($0.05)($0.04)+$0.01($0.06)$31.00 million$34.76 million    
9/6/2022Q1 2023$0.03$0.02($0.01)$0.02$34.00 million$36.69 million
6/29/2022Q4 2022($0.02)$0.04+$0.06($1.57)$29.20 million$31.23 million
3/8/2022Q3 2022$0.05$0.06+$0.01$0.08$28.00 million$31.51 million    
12/7/202110/31/2021$0.02$0.06+$0.04$0.08$25.00 million$26.11 million    
9/7/20217/31/2021$0.04$0.10+$0.06$0.10$25.00 million$30.75 million    
6/28/20214/30/2021$0.01($0.04)($0.05)($0.04)$20.70 million$27.61 million    
3/7/20211/31/2021($0.03)$0.01+$0.04$0.01$20.00 million$21.81 million  
12/1/202010/31/2020($0.06)$0.01+$0.07$0.01$14.00 million$21.06 million  
9/1/20207/31/2020($0.06)$0.06+$0.12$0.06$25.39 million  
6/30/20204/30/2020($0.16)($0.11)+$0.05($0.11)$9.55 million$12.55 million  
3/10/20201/31/2020($0.03)($0.06)($0.03)($0.06)$16.80 million$13.59 million  
12/9/2019Q2($0.04)($0.03)+$0.01($0.03)$14.34 million$18.31 million  
9/5/2019Q1($0.03)($0.08)($0.05)($0.08)$14.37 million$15.25 million  
6/27/2019Q4($0.03)($0.02)+$0.01($0.02)$15.53 million$17.06 million  
3/11/20191/31/2019($0.07)($0.05)+$0.02($0.05)$13.43 million$13.78 million  
12/10/201810/31/2018($0.09)($0.06)+$0.03($0.07)$10.75 million$10.18 million  
9/10/2018Q1 2019($0.09)($0.06)+$0.03($0.06)$9.95 million$12.59 million  
7/16/2018Q4 2018($0.15)$0.05+$0.20($0.31)$6.51 million$6.94 million
3/12/2018Q3 2018($0.14)($0.23)($0.09)($0.18)$8.95 million$6.82 million  
12/11/2017Q2 2018($0.12)($0.27)($0.15)($0.23)$13.54 million$12.78 million
9/11/2017Q1 2018($0.12)($0.06)+$0.06($0.06)$15.22 million$27.08 million
7/14/2017Q4 2017($0.07)($0.16)($0.09)($0.16)$22.57 million$17.90 million
3/13/2017Q3 2017($0.21)($0.28)($0.07)($0.28)$14.02 million$10.75 million
12/12/2016Q2 2017($0.21)($0.14)+$0.07($0.14)$587.49 million$23.40 million
9/8/2016Q1 2017($0.28)($0.35)($0.07)($0.35)$13.08 million$5.61 million
7/14/2016Q4 2016($0.21)($0.35)($0.14)($0.35)$15.80 million$18.78 million  
3/9/2016Q3 2016($0.49)($0.56)($0.07)($0.56)$7.96 million$6.71 million  
12/10/2015Q2 2016($0.63)($0.49)+$0.14($0.49)$7.35 million$9.52 million  
9/9/2015Q1 2016($0.56)($0.56)($0.56)$7.96 million$9.67 million
7/14/2015Q4 2015($0.49)($0.49)($0.49)$6.42 million$9.31 million  
3/12/2015Q3 2015($0.56)($0.56)($0.56)$4.20 million$5.68 million
12/10/2014Q2 2015($0.56)($0.49)+$0.07($0.49)$5.82 million$6.30 million
9/9/2014Q1 2015($0.42)($0.56)($0.14)($0.56)$5.76 million$5.50 million  
7/14/2014Q4 2014($0.56)($0.42)+$0.14($0.42)$4.75 million$6.47 million
3/7/2014Q3 2014($0.49)($0.42)+$0.07($0.42)$5.09 million$3.90 million
12/10/2013Q2 2014($0.35)($0.35)($0.35)$5.74 million$7.35 million  
9/9/2013Q1 2014($0.35)($0.35)($0.35)$4.75 million$4.69 million
7/11/2013Q4 2013($0.42)($0.42)($0.42)$3.57 million$4.25 million
3/12/2013Q3 2013($0.42)($0.28)+$0.14($0.28)$3.90 million$7.04 million  
12/10/2012-0.08($0.63)($0.56)+$0.07$4.03 million$4.03 million
9/10/2012Q113($0.77)($0.49)+$0.28$3.97 million$4.25 million
7/16/2012($0.91)($0.70)+$0.21
3/9/2012($0.91)($0.91)
12/12/2011($0.91)($1.12)($0.21)  
9/9/2011($0.98)($0.77)+$0.21
7/14/2011Q4 2011($1.12)($1.05)+$0.07($1.05)
3/11/2011Q3 2011($0.91)($0.97)($0.06)($0.97)
12/9/2010Q2 2011($0.84)($0.92)($0.08)($0.92)
9/9/2010Q1 2011($0.70)($0.99)($0.29)($0.99)
7/14/2010Q4 2010($0.70)($1.12)($0.42)($1.12)
3/11/2010Q3 2010($0.22)($0.22)($0.22)
12/10/2009Q2 2010($0.41)($0.41)($0.41)
9/3/2009Q1 2010($0.35)($0.35)($0.35)
7/14/2009Q4 2009($0.70)($0.70)($0.70)
3/11/2009Q3 2009($0.35)($0.52)($0.17)($0.52)
12/10/2008Q2 2009($0.70)($0.70)($0.70)
9/9/2008Q1 2009($0.77)($0.77)($0.77)
7/14/2008Q4 2008($0.70)($0.70)($0.70)
3/11/2008Q3 2008($0.94)($0.94)($0.94)












Avid Bioservices Earnings - Frequently Asked Questions

When is Avid Bioservices's earnings date?

Avid Bioservices has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 5th, 2023 based off last year's report dates. Learn more on CDMO's earnings history.

How much revenue does Avid Bioservices generate each year?

Avid Bioservices (NASDAQ:CDMO) has a recorded annual revenue of $119.60 million.

How much profit does Avid Bioservices generate each year?

Avid Bioservices (NASDAQ:CDMO) has a recorded net income of $127.67 million. CDMO has generated $1.66 earnings per share over the last four quarters.

What is Avid Bioservices's price-to-earnings ratio?

Avid Bioservices (NASDAQ:CDMO) has a trailing price-to-earnings ratio of 10.56.

What is Avid Bioservices's EPS forecast for next year?

Avid Bioservices's earnings are expected to grow from ($0.04) per share to $0.10 per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CDMO) was last updated on 3/23/2023 by MarketBeat.com Staff